TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 196 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,887,000 | -14.0% | 25,078 | -69.3% | 0.00% | 0.0% |
| Q1 2022 | $2,193,000 | -43.7% | 81,681 | +0.1% | 0.00% | -50.0% |
| Q4 2021 | $3,892,000 | -34.1% | 81,588 | -8.2% | 0.00% | -33.3% |
| Q3 2021 | $5,903,000 | -6.5% | 88,866 | +9.9% | 0.00% | 0.0% |
| Q2 2021 | $6,310,000 | +19.2% | 80,869 | +44.5% | 0.00% | 0.0% |
| Q1 2021 | $5,294,000 | -26.4% | 55,972 | -5.2% | 0.00% | -25.0% |
| Q4 2020 | $7,195,000 | +210.3% | 59,042 | +122.4% | 0.00% | +100.0% |
| Q3 2020 | $2,319,000 | +20.2% | 26,549 | -11.2% | 0.00% | +100.0% |
| Q2 2020 | $1,930,000 | +126.3% | 29,892 | +56.6% | 0.00% | 0.0% |
| Q1 2020 | $853,000 | -5.3% | 19,093 | +31.6% | 0.00% | 0.0% |
| Q4 2019 | $901,000 | +1101.3% | 14,505 | +602.4% | 0.00% | – |
| Q3 2019 | $75,000 | -77.9% | 2,065 | -75.4% | 0.00% | – |
| Q2 2019 | $339,000 | – | 8,385 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |